首页 > 抗体蛋白 > 抗体
Alexa Fluor® 700 anti-mouse NK-1.1 Antibody
产品名称:
Alexa Fluor® 700 anti-mouse NK-1.1 Antibody
产品类别:
抗体
产品编号:
108729
产品应用:
108729
[价格]
规格 价格 库存
25µg ¥ 1386 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
NK-1+ cells from mouse spleen and bone marrow
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis.?The suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor? 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor? 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, complement-dependent cytotoxicity3, in vivo depletion4,5,9,10, mediation of in vitro redirected lysis6, blocking of NK cell function7, induction of proliferation8, immunohistochemical staining of frozen sections11, immunofluorescence microscopy11, and spatial biology (IBEX)16,17. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 108712).

Application References

(PubMed link indicates BioLegend citation)
  1. Carlyle JR, et al. 1999. J. Immunol. 162:5917. (IP)
  2. Sentman CL, et al. 1989. Hybridoma 8:605. (IP)
  3. Koo GC, et al. 1984. Hybridoma 3:301. (Cyt)
  4. Sentman CL, et al. 1989. J. Immunol. 142:1847. (Deplete)
  5. Koo GC, et al. 1986. J. Immunol. 137:3742. (Deplete)
  6. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  7. Kung SK, et al. 1999. J. Immunol. 162:5876. (Block)
  8. Reichlin A, et al. 1998. Immunol. Cell Biol. 76:143.
  9. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
  10. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (Deplete)
  11. Kanwar JR, et al. 2001. J. Natl. Cancer Inst. 93:1541. (IHC, IF)
  12. Kroemer A, et al. 2008. J. Immunol. 180:7818. PubMed
  13. Kim JY, et al. 2009. Exp Mol Med. 30:288. PubMed
  14. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  15. Lee H, et al. 2014. Invest Ophthalmol Vis Sci. 55:2885. PubMed
  16. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  17. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  2. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  3. Trittel S, et al. 2019. Sci Rep. 9:16362. PubMed
  4. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  5. Hreha TN, et al. 2020. Front Immunol. 1.597916667. PubMed
  6. Laumonnier Y, et al. 2020. Curr Protoc Immunol. 130:e100. PubMed
  7. Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
  8. Niss K, et al. 2020. Cell Reports. 31(11):107763. PubMed
  9. Roy R, et al. 2022. Elife. 11:. PubMed
  10. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  11. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  12. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  13. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  14. Baier FA, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:745. PubMed
  15. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  16. Holm J, et al. 2015. PLoS One. 10:125495. PubMed
  17. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  18. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  19. Soberanes S et al. 2018. Cell metabolism. 29(2):335-347 . PubMed
  20. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  21. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  22. RL M, et al. 2015. Proc Natl Acad Sci U S A. 112:6506-6514. PubMed
  23. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  24. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  25. Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
RRID
AB_2074426 (BioLegend Cat. No. 108729) AB_2291262 (BioLegend Cat. No. 108730)

Antigen Details

Structure
NKR-P1 gene family
Distribution

NK and NK-T cells in the NK1.1 mouse strains (C57BL, FVB/N, NZB)

Function
NK cell activation, IFN-γ production, cytotoxic granule release
Cell Type
NK cells, NKT cells
Biology Area
Immunology, Innate Immunity
Antigen References

1. Lanier LL. 1997. Immunity 6:371.
2. Yokoyama WM, et al. 1993. Ann. Rev. Immunol. 11:613.
3. Koo GC, et al. 1986. J. Immunol. 137:3742.
4. Giorda R, et al. 1991. J. Immunol. 147:1701.

Gene ID
17059 View all products for this Gene ID
UniProt
View information about NK-1.1 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线